U.S. growth stocks have significantly outperformed value stocks over the past year, but we believe this dynamic could shift as near-term challenges fade.
T. Rowe Price’s Asset Allocation Committee has moved to overweight U.S. value stocks, as earnings expectations appear to leave room for an upside surprise.
